Literature DB >> 3609510

Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion.

R J Salvi, W Ahroon, S S Saunders, S A Arnold.   

Abstract

A computer-automated, threshold-tracking procedure was developed for measuring evoked response thresholds on-line. The procedure utilizes an objective detection criterion (correlation) to evaluate whether a response is absent or present. Sound intensity is adjusted according to a modified PEST (parameter estimation by sequential testing) procedure in order to estimate threshold. The computer-automated procedures were used to obtain objective estimates of evoked response thresholds in normal and hearing-impaired chinchillas. The evoked response waveforms stored in the computer were also used to obtain visual judgments of threshold. The objective thresholds determined by the computer were virtually identical to the visual detection thresholds. Thus, the computer-automated procedure provides a reliable, objective, and efficient method of estimating evoked response thresholds.

Entities:  

Mesh:

Year:  1987        PMID: 3609510

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  78 in total

1.  Amplification of DNA from native populations of soil bacteria by using the polymerase chain reaction.

Authors:  K D Bruce; W D Hiorns; J L Hobman; A M Osborn; P Strike; D A Ritchie
Journal:  Appl Environ Microbiol       Date:  1992-10       Impact factor: 4.792

2.  Ribotyping for strain characterization of Clostridium perfringens isolates from food poisoning cases and outbreaks.

Authors:  B Schalch; J Björkroth; H Eisgruber; H Korkeala; A Stolle
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

3.  Integration of heterologous plasmid DNA into multiple sites on the genome of Campylobacter coli following natural transformation.

Authors:  P T Richardson; S F Park
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

4.  Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.

Authors:  K Muhlemann; M Balz; S Aebi; K Schopfer
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis.

Authors:  P M Desmarchelier; D A Dance; W Chaowagul; Y Suputtamongkol; N J White; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Subdivision of Burkholderia pseudomallei ribotypes into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology.

Authors:  A Haase; H Smith-Vaughan; A Melder; Y Wood; A Janmaat; J Gilfedder; D Kemp; B Currie
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

7.  The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein.

Authors:  P W O'Toole; L Janzon; P Doig; J Huang; M Kostrzynska; T J Trust
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

8.  Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli.

Authors:  J Frey; H van den Bosch; R Segers; J Nicolet
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  C L Clayton; H Kleanthous; D D Morgan; L Puckey; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  Discrimination of epidemic and sporadic isolates of Arcobacter butzleri by polymerase chain reaction-mediated DNA fingerprinting.

Authors:  P Vandamme; B A Giesendorf; A van Belkum; D Pierard; S Lauwers; K Kersters; J P Butzler; H Goossens; W G Quint
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.